Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

121.39 +0.25 (+0.21%)

Streaming Delayed Price Updated: 3:37 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9

...

51 52 Next >

Top S&P500 movers in Friday's session ↗

July 18, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield ↗

July 18, 2025

Abbott Laboratories' dividend is safe, the pipeline is strong, and the outlook for growth is positive, making the July price dip a buying opportunity.

Via MarketBeat

These Analysts Revise Their Forecasts On Abbott Following Q2 Results ↗

July 18, 2025

Via Benzinga

Microsoft To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday ↗

July 18, 2025

Via Benzinga

P/E Ratio Insights for Abbott Laboratories ↗

July 17, 2025

Via Benzinga

A Preview Of Abbott Laboratories's Earnings ↗

July 16, 2025

Via Benzinga

ABT Q1 Deep Dive: Growth in Devices, Product Pipeline, and Tariff Mitigation Shape Outlook

July 18, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of...

Via StockStory

Topics Economy World Trade

Abbott Reports 12% Growth in Device Sales ↗

July 17, 2025

Via The Motley Fool

Top S&P500 movers in Thursday's session ↗

July 17, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Why Abbott Laboratories (ABT) Shares Are Plunging Today

July 17, 2025

Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.1% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations but...

Via StockStory

Unusual volume S&P500 stocks in Thursday's session ↗

July 17, 2025

Let's have a look at the S&P500 stocks with an unusual volume in today's session.

Via Chartmill

Nasdaq 100 Sets New Records, Small Caps Outperform: What's Moving Markets Thursday? ↗

July 17, 2025

U.S. equities climbed on Thursday, with the S&P 500 briefly testing a record high 6,300 level at midday in New York, bolstered by strong earnings and upbeat retail sales data that reinforced investor...

Via Benzinga

Abbott Reports 10.5% EPS Growth for Fiscal Q2 ↗

July 17, 2025

Via The Motley Fool

Topics Economy World Trade

Stay informed with the top movers within the S&P500 index on Thursday. ↗

July 17, 2025

Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.

Via Chartmill

Abbott (ABT) Q2 2025 Earnings Call Transcript ↗

July 17, 2025

Via The Motley Fool

Topics Earnings

Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors ↗

July 17, 2025

Abbott posted Q2 revenue of $11.14 billion and EPS of $1.26, raised 2025 earnings guidance, and saw strong growth in diabetes and heart device sales.

Via Benzinga

Which S&P500 stocks are gapping on Thursday? ↗

July 17, 2025

Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Via Chartmill

Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hours ↗

July 17, 2025

Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said.

Via Stocktwits

Topics Artificial Intelligence

Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss ↗

July 17, 2025

The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.

Via Investor's Business Daily

Topics Government Stocks

Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

July 17, 2025

Via Benzinga

Wondering what's happening in today's S&P500 pre-market session? ↗

July 17, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

Dow Futures Edge Lower As Trump, Powell Feud Escalates, Earnings Take Centerstage: TSMC, PEP, UAL, GE Among Stocks To Watch ↗

July 17, 2025

While Dow Jones futures were down 0.12% at the time of writing, the S&P 500 futures were up 0.06%.

Via Stocktwits

Topics ETFs Economy Government

Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates

July 17, 2025

Via StockStory

Earnings Scheduled For July 17, 2025 ↗

July 17, 2025

Via Benzinga

Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

July 16, 2025

Via Benzinga

Nvidia To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

July 16, 2025

Via Benzinga

Abbott Laboratories (ABT) Q2 Earnings: What To Expect

July 15, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results this Thursday morning. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Meta To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

July 15, 2025

Via Benzinga

3 Profitable Stocks to Research Further

July 14, 2025

Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

Via StockStory

Topics Economy Supply Chain

Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity

July 15, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ABT),(NASDAQ:DXCM),(NASDAQ:IRTC),(NASDAQ:TNDM) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.